# SSX4B

## Overview
SSX4B is a gene that encodes the protein SSX family member 4B, which is part of the synovial sarcoma X (SSX) family of proteins. These proteins are categorized as cancer/testis (CT) antigens, typically expressed in germ cells and aberrantly activated in various cancers. The SSX4B protein is implicated in oncogenesis, particularly in the context of multiple myeloma, where its expression is upregulated in specific molecular clusters identified through gene expression profiling (Broyl2010Gene). This upregulation suggests a role in the pathogenesis and heterogeneity of the disease (Broyl2010Gene). The aberrant expression of SSX4B in cancerous tissues makes it a potential target for cancer immunotherapy and a candidate biomarker for cancer diagnosis and treatment (Chen2005Identification).

## Structure


## Clinical Significance
SSX4B, a member of the synovial sarcoma X (SSX) gene family, is implicated in cancer development, particularly in multiple myeloma. Alterations in the expression of SSX4B have been associated with the molecular classification of multiple myeloma, where it is upregulated in certain clusters. These clusters, identified through gene expression profiling, include a CTA-like cluster characterized by the upregulation of SSX4B, among other genes (Broyl2010Gene). The presence of SSX4B in these clusters suggests its potential role in the pathogenesis of multiple myeloma, contributing to the complexity and heterogeneity of the disease (Broyl2010Gene).

The SSX4B gene is also part of the broader cancer/testis (CT) antigen family, which is typically expressed in germ cells but can be aberrantly activated in various cancers. This aberrant expression makes SSX4B a potential target for cancer immunotherapy, as CT antigens are often associated with tumor-specific expression patterns (Chen2005Identification). The identification of SSX4B and its expression in cancerous tissues highlights its significance in oncogenesis and its potential as a biomarker for cancer diagnosis and treatment strategies.


## References


[1. (Broyl2010Gene) Annemiek Broyl, Dirk Hose, Henk Lokhorst, Yvonne de Knegt, Justine Peeters, Anna Jauch, Uta Bertsch, Arjan Buijs, Marian Stevens-Kroef, H. Berna Beverloo, Edo Vellenga, Sonja Zweegman, Marie-Josée Kersten, Bronno van der Holt, Laila el Jarari, George Mulligan, Hartmut Goldschmidt, Mark van Duin, and Pieter Sonneveld. Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients. Blood, 116(14):2543–2553, October 2010. URL: http://dx.doi.org/10.1182/blood-2009-12-261032, doi:10.1182/blood-2009-12-261032. This article has 251 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2009-12-261032)

[2. (Chen2005Identification) Yao‐Tseng Chen, Christian Iseli, Charis A. Venditti, Lloyd J. Old, Andrew J. G. Simpson, and C. Victor Jongeneel. Identification of a new cancer/testis gene family, ct47, among expressed multicopy genes on the human x chromosome. Genes, Chromosomes and Cancer, 45(4):392–400, December 2005. URL: http://dx.doi.org/10.1002/gcc.20298, doi:10.1002/gcc.20298. This article has 30 citations.](https://doi.org/10.1002/gcc.20298)